Paul D Goldenheim

This inventor holds 37 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Analgesic Formulations. Top assignees: Euro-Celtique S.a., Purdue Pharma L.p., Allergan, Inc.. Active years: 1995-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul D Goldenheim. Retrieved from https://idiyas.com/inventor/paul-d-goldenheim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 37 (Patent Applications = 8)

% Patents Active = 78.4

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 3.7

ph-index = 23

Forward Citations = 3,337(Granted Patents)

Location History:

Wilson, CT (US) (2010)
Wilton, CT (US) (1995 - 2014)
Cambridge, MA (US) (2015 - 2020)

Company Filing History:

4. 1 out of 834,453

Other

patents

Years Active: 1995-2020

Loading Chart...

Areas of Expertise:

Analgesic Combination

Sustained Analgesia

Local Anesthesia

Opioid Formulations

Controlled Release

Pelvic Pain Treatment

Bladder Pain Treatment

Methylphenidate Formulations

Prolonged Anesthesia

Tramadol Formulations

Oxycodone

Buprenorphine

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10617657 - Devices and methods for sustained treatment of bladder pain and irritative voiding (2020-04-14),

2. 10123981 - Methods for treatment of pelvic pain and/or comorbid conditions (2018-11-13),

3. 9642850 - Method of providing sustained analgesia with buprenorphine (2017-05-09),

4. 9387163 - Methods for treatment of pelvic pain and/or comorbid conditions (2016-07-12),

5. 9114111 - Methods for sustained treatment of bladder pain and irritative voiding (2015-08-25),

6. 8685994 - Analgesic combination of oxycodone and celecoxib (2014-04-01),

7. 8193209 - Analgesic combination of oxycodone and meloxicam (2012-06-05),

8. 8188107 - Analgesic combination of oxycodone and N-[3-(formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl] methanesulfonamide (2012-05-29),

9. 8168629 - Analgesic combination of tramadol and meloxicam (2012-05-01),

10. 8143267 - Analgesic combination of oxycodone and nimesulide (2012-03-27),

11. RE41571 - Method of providing sustained analgesia with buprenorphine (2010-08-23),

12. RE41489 - Method of providing sustained analgesia with buprenorphine (2010-08-09),

13. RE41408 - Method of providing sustained analgesia with buprenorpine (2010-06-28),

14. 7740881 - Method of treating humans with opioid formulations having extended controlled release (2010-06-22),

15. 7083808 - Controlled/modified release oral methylphenidate formulations (2006-08-01),

Title: The Legacy of Paul D Goldenheim

Introduction: Paul D Goldenheim, a renowned inventor hailing from Wilton, CT (US), has left an indelible mark on the world of innovation with his groundbreaking contributions.

Latest Patents: Paul D Goldenheim's latest patents showcase his continued dedication to pushing the boundaries of technology and science, with a focus on improving healthcare and sustainability.

Career Highlights: With a distinguished career spanning several decades, Paul D Goldenheim has held key roles in various research institutions and companies, leading teams to develop cutting-edge solutions in pharmaceuticals, biotechnology, and beyond.

Collaborations: Throughout his career, Paul D Goldenheim has collaborated with top universities, research institutions, and industry leaders, fostering a culture of innovation and knowledge-sharing that has paved the way for numerous breakthroughs.

Conclusion: Paul D Goldenheim's passion for innovation, coupled with his relentless pursuit of excellence, has solidified his reputation as a visionary inventor whose impact will be felt for generations to come.

Profile summary based on public USPTO records.